Abstract
It is remarkable that phytoplankton and zooplankton have been producing vitamin D for more than 500 million years. The role of vitamin D in lower nonvertebrate life forms is not well understood. However, it is critically important that most vertebrates obtain an adequate source of vitamin D, either from exposure to sunlight or from their diet, in order to develop and maintain a healthy mineralized skeleton. Vitamin D deficiency is an unrecognized epidemic in most adults who are not exposed to adequate sunlight. This can precipitate and exacerbate osteoporosis and cause the painful bone disease osteomalacia. Once vitamin D is absorbed from the diet or made in the skin by the action of sunlight, it is metabolized in the liver to 25-hydroxyvitamin D [25(OH)D] and then in the kidney to 1,25-dihydroxyvitamin D [1,25(OH)2D3]. 1,25(OH)2D3interacts with its nuclear receptor (VDR) in the intestine and bone in order to maintain calcium homeostasis. The VDR is also present in a wide variety of other tissues. 1,25(OH)2D3interacts with these receptors to have a multitude of important physiological effects. In addition, it is now recognized that many tissues, including colon, breast and prostate, have the enzymatic machinery to produce 1,25(OH)2D3. The insights into the new biological functions of 1,25(OH)2D3in regulating cell growth, modulating the immune system and modulating the renin-angiotensin system provides an explanation for why diminished sun exposure at higher latitudes is associated with increased risk of dying of many common cancers, developing type 1 diabetes and multiple sclerosis, and having a higher incidence of hypertension. Another calciotropic hormone that is also produced in the skin, parathyroid hormone-related peptide, is also a potent inhibitor of squamous cell proliferation. The use of agonists and antagonists for PTHrP has important clinical applications for the prevention and treatment of skin diseases and disorders of hair growth.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Adams JS, Gacad MA, Diz MM, Nadler JL (1990) A role for endogenous archidonate metabolites in the regulated expression of the 25-hydroyvitamin d-1-hydroxylation reaction in cultured alveolar macrophages from patients with sarcoidosis. J Clin Endo Metab 70:595–600
Apperly FL (1941) The relation of solar radiation to cancer mortality in North America. Cancer Res 1:191–195
Bell NH, Greene A, Epstein S, Oexmann MJ, Shaw S, Shary J (1985) Evidence for alteration of the vitamin D-endocrine system in blacks. J Pedr 76:470–473
Bikle DD, Nemanic MK, Gee E, Elias P (1986) 1,25-Dihydroxyvitamin D3 production by human keratinocytes: kinetics and regulation. J Clin Invest 78:557–566
Bills CE (1924) Studies on the antiricketic vitamin. Ph.D. Dissertation, Johns Hopkins Univ. Press, Baltimore, MD
Bills CE (1927) Antirachitic substances. VI. The distribution of vitamin D with some notes on its possible origins. J Biol Chem 72:751–758
Broadus AE, Mangin M, Ikeda K et al (1988) Humoral hypercalcemia of cancer: identification of a novel parathyroid hormone-like peptide. N Engl J Med 319:556–563
Cantorna MT, Hayes CE, DeLuca HF (1996) 1,25-Dihydroxyvitamin D3 reversibly blocks the progression of relapsing encephalomyelitis, a model of multiple sclerosis. Proc Natl Acad Sci 93:7861–7864
Chel VGM, Ooms ME, Popp-Snijders C, Pavel S, Schothorst AA, Meulemans CCE, Lips P (1998) Ultraviolet irradiation corrects vitamin D deficiency and suppresses secondary hyperparathyroidism in the elderly. J Bone Miner Res 13:1238–1242
Chen T C (1999) Photobiology of vitamin D. In: Holick M F (ed) Vitamin D physiology, molecular biology, and clinical applications. Humana Press, Totowa, New Jersey
Chuck A, Todd J, Diffey B (2001) Subliminal ultraviolet-B irradiation for the prevention of vitamin D deficiency in the elderly: a feasibility study. Photochem Photoimmun Photomed 17,168–171
Chun Y, Kong J et al (2002) 1,25-dihydroxyvitamin D3 is a negative endocrine regulator of the renin-angiotension system. J Clin Invest 110:229–238
Clemens TL, Henderson SL, Adams JS, Holick MF (1982) Increased skin pigment reduces the capacity of skin to synthesize vitamin D3. Lancet 74–76
Colston K, Colston MJ, Feldman D (1981) 1,25-Dihydroxyvitamin D3 and malignant melanoma: the presence of receptors and inhibition of cell growth in culture. Endocrinol 108:1083–1086
Copping AM (1934) Origin of vitamin D in cod-liver oil: vitamin D content zooplankton. J Biol Chem 28:1516–1520
Cross HS, Bareis P, Hofer H et al (2001) 25-Hydroxyvitamin D3–1a-hydroxylase and vitamin D receptor gene expression in human colonic mucosa is elevated during early cancerogenesis. Steroids 66:287–292
Danks JA, Martin TJ, Moseley JM, Hayman JA (1991) Do all epidermal keratinocytes contain parathyroid hormone related protein (PTHrP)? J Invest Dermatol 97:1086–1087
Drummond JC, Gunther ER (1930) Vitamin content in marine plankton. Nature (London) 126:398
Eisman JA (1984) 1,25-Dihydroxyvitamin D3 receptor and role of 1,25-dihydroxyvitamin D3 in human cancer cells in vitamin D. In: Kumar R (ed) Vitamin D: basic and clinical aspects. Martinus Nijhoff, Boston, pp 365–382
Feldman D, Zhao XY, Krishnan AV (2000) Editorial/mini-review: vitamin D and prostate cancer. Endocrinology 141: 5–9
Flanagan JN, Whitlatch LW, Chen TC, Zhu XH, Holick MT, Kong X, Holick MF (2001) Enhancing a,-hydroxylase activity with the 25-hydroxyvitamin D-1a-hydroxylase gene in cultured human keratinocytes and mouse skin. J Invest Dermatol 116:910–914
Fu GK, Portale AA, Miller WL (1997) Complete structure of the human gene for the vitamin D 1a-hydroxylase, p450c1a. DNA Cell Biol 16:1499–1507
Garland CF, Garland FC, Shaw EK, Comstock GW, Helsing KJ, Gorham ED (1989) Serum 25-hydroxyvitamin D and colon cancer: eight-year prospective study. Lancet 2 (8673):1176–1178
Garland FC, Garland CF, Gorham ED, Young JF (1990) Geographic variation in breast cancer mortality in the United States: a hypothesis involving exposure to solar radiation. Preventive Med 19:614–622
Glerup H, Middelsen K, Poulsen L, Hass E, Overbeck S, Andersen H, Charles P, Eriksen EF (2000) Hypovitaminosis D myopathy without biochemical signs of osteomalacia bone involvement. Calcif Tissue Int 66:419–424
Hanchette CL, Schwartz GG (1992) Geographic patterns of prostate cancer mortality. Cancer 70:2861–2869
Hess AF, Unger LF (1921) Cure of infantile rickets by sunlight. J Am Med Assoc 77:39–39
Hess AF, Weinstock M (1924) Antirachitic properties imparted to inert fluids and green vegetables by ultraviolet irradiation. J Biol Chem 62:301–313
Holick MF (1989) Phylogenetic and evolutionary aspects of vitamin D from phytoplankton to humans. In: Pang P and Schreibman M (ed) Vertebrate endocrinology: fundamentals and biomedical implications. Academic, San Diego, pp 7–43
Holick MF (1994) Vitamin D: new horizons for the 21st century. Am J Clin Nutr 60:619–630
Holick MF (1998) Clinical efficacy of 1,25-dihydroxyvitamin D3 and its analogues in the treatment of psoriasis. Retinoids 14:12–17
Holick MF (1999a) Biologic effects of light: historical and new perspectives. In: Holick MF, Jung EG (ed) Biologic effects of light 1998. Kluwer, Boston, pp 11–32
Holick MF (1999b) Noncalcemic actions of 1,25-dihydroxyvitamin D3 and clinical Implications. In: Holick MF (ed) Vitamin D – Physiology, molecular biology and clinical applications. Humana Press, Totowa, pp 207–216
Holick MF (2001) Metabolic bone disease. In: Noble J (ed) Textbook of primary care medicine, 3rd edn. Mosby, St. Louis, pp 387–395
Holick MF (2002a) Vitamin D: importance for bone health, cellular health and cancer prevention. In: Holick MF (ed) Biologic effects of light 2001. Kluwer, Boston, pp 155–173
Holick MF (2002b) Vitamin D: the underappreciated D-lightful hormone that is important for skeletal and cellular health. Curr Opin Endocrinol Diabetes 9:87–98
Holick MF (2002c) Vitamin D: a millennium perspective. J Cell Bio Chem J Cell Biochem 88:296–307
Holick MF (2002d) Sunlight and vitamin D, both good for cardiovascular health. J Gen Intern Med Sep;17:733–735
Holick MF, MacLaughlin JA, Doppelt SH (1981) Regulation of cutaneous previtamin D3 photosynthesis in man: skin pigment is not an essential regulator. Science 211:590–593
Holick MF, Holick SA, Guillard RL (1982a) On the origin of metabolism of vitamin D in the sea. In: Oguro C, Pang P (eds) Comparative endocrinology and calcium regulation. Sci Soc Press, Tokyo, pp 85–91
Holick MF, Holick SA, Guillard RL (1982b) Photosynthesis of previtamin D in phytoplankton. In: Lofts B, Holmes W N (eds) Current trends in comparative endocrinology. Hong Kong University Press, Hong Kong, pp 1263–1266
Holick MF, Matsuoka LY, Wortsman J (1989) Age, vitamin D, and solar ultraviolet radiation. Lancet 4:1104–1105
Holick MF, Ray S, Chen T, Tian X, Persons K (1994) Novel functions of a parathyroid hormone antagonist: stimulation of epidermal proliferation and hair growth in mice. Proc Natl Acad Sci 91:8014–8016
Holick MF, Tian XQ, Allen M (1995) Evolutionary importance for the membrane enhancement of the production of vitamin D3 in the skin of poikilothermic animals. Proc Natl Acad Sci 92:3124–3126
Holick MF, Chen, ML, Kong XF, Sanan DK (1996) Clinical uses for calciotropic hormones 1,25-dihydroxyvitamin D3 and parathyroid hormone-related peptide in dermatology: a new perspective. J Invest Dermatol 1:1–9
Hosomi J, Hosoi J, Abe E, Suda T, Kuroki T (1983) Regulation of terminal differentiation of cultured mouse epidermal cells by 1a,25-dihydroxyvitamin D3. Endocrinology 113:1950–1957
Huldschinsky K (1919) Heilung von Rachitis durch Kunstliche Hohensonne. Deutsche Med Wochenschr 45:712–713
Hypponen E, Laara E, Reunanen A, Jarvelin MR, Virtanen SM (2001) Intake of vitamin D and risk of type 1 diabetes: a birth-cohort study. Lancet 358:1500–1503
Jacobus CH, Holick MF, Shao Q, Chen TC, Holm IA, Kolodny JM, El-Hajj Fuleihan G, Seel, E (1992) Hypervitaminosis D associated with drinking milk. N Engl J Med 326:1173–1177
Jimi E, Nakamura I, Amano H, Taguchi Y, Tsurukai T, Tamura M, Takahashi N, Suda T (1996) Osteoclast function is activated by osteoblastic cells through a mechanism involving cell-to-cell contact. Endocrinology 137:2187–2190
Juhlin L, Hagforsen E, Juhlin C (1992) Parathyroid hormone related protein is localized in the granular layer of normal skin and in the dermal infiltrates of mycosis fungoides but is absent in psoriatic lesions. Acta Derm Venerol 72:81–83
Kato T, Rokugo M, Terui T, Tagami H (1986) Successful treatment of psoriasis with topical application of active vitamin D3 analogue, 1a,24-dihydroxycholecalciferol. Br J Dermatol 115:431–433
Kato S (2001) Vitamin D 1-hydroxylase knockout mice as a hereditary rickets animal. Endocrinology 142: 2734–3735
Kenny DE, Irlbeck NA, Eller JL (1999) Rickets in two hand-reared polar bear (Ursus Maritimus) cubs. J Zoo Wildlife Med 30:132–140
Kong XF, Zhu XH, Pei YL, Jackson DM, Holick MF (1997) Molecular cloning, characterization, and promoter analysis of the human 25-hydroxyvitamin D3–1a-hydroxylase gene. Proc Natl Acad Sci USA 96:6988–6993
Kragballe K, Beck HI, Sogaard H (1988) Improvement of psoriasis by a topical vitamin D3 analogue (MC903) in a double-blind study. Br J Dermatol 119:223–230
Kreiter SR, Schwartz RP, Kirkman HN, Charlton PA, Calikoglu AS, Davenport ML (2000) Nutritional rickets in African American breast-fed infants. J Pediatr 137:153–157
Lanske B, Amling M, Neff L, Guiducci J, Baron R, Kronenberg HM (1999) Ablation of the PTHrP gene or the PTH/PTHrP receptor gene leads to distinct abnormalities in bone development. J Clin Invest 104:399–407
Lehmann B (1997) HaCaT cell line as a model system for vitamin D3 metabolism in human skin. J Invest Dermatol 108:78–82
MacLaughlin J, Holick MF (1985) Aging decreases the capacity of human skin to produce vitamin D3. J Clin Invest 76:1536–1538
MacLaughlin JA, Anderson RR, Holick MF (1982) Spectral character of sunlight modulates photosynthesis of previtamin D3 and its photoisomers in human skin. Science 216:1001–1004
MacLaughlin JA, Gange W, Taylor D, Smith E, Holick MF (1995) Cultured psoriatic fibroblasts from involved and uninvolved sites have a partial but not complete resistance to the proliferation–inhibition of 1,25-dihydroxyvitamin D3. Proc Natl Acad Sci USA 82:5904–5912
Malabanan A, Veronikis IE, Holick MF (1998) Redefining vitamin D insufficiency. Lancet 351:805–806
Manolagas SC, Provvedini DM, Tsoukas CD (1985) Interactions of 1,25-dihydroxyvitamin D3 and the immune system. Mol Cell Endocrinol 43:113–122
Mathieu C, Waer M, Laureys J et al (1994) Prevention of autoimmune diabetes in NOD mice by 1,25 dihydroxyvitamin D3. Diabetologia 37:552–558
Matsuoka LY, Ide L, Wortsman J, MacLaughlin J, Holick MF (1987) Sunscreens suppress cutaneous vitamin D3 synthesis. J Clin Endocrinol Metab 64:1165–1168
Matsuoka LY, Wortsman J, Hanifan N, Holick MF (1988) Chronic sunscreen use decreases circulating concentrations of 25- hydroxyvitamin D: a preliminary study. Arch Derm 124:1802–1804
Matsuoka LY, Wortsman J, Dannenberg MJ, Hollis BW, Lu Z, Holick MF (1992) Clothing prevents ultraviolet-B radiation-dependent photosynthesis of vitamin D. J Clin Endocrinol Metab 75:1099–1103
Mellanby T (1918) The part played by an “accessory factor“ in the production of experimental rickets. J Physiol 52:11–14
Morris JG (1999) Defective vitamin D synthesis in cats is reversed by an inhibitor of 7-dehydrocholesterol-delta7-reductase. Am Soc Nutr Sci
Palm TA (1890) The geographic distribution and etiology of rickets. Practioner 45:270–342
Perez A, Chen TC, Turner A, Raab R, Bhawan J, Poche P, Holick MF (1996) Efficacy and safety of topical calcitriol (1,25-dihydroxyvitamin D3) for the treatment of psoriasis. Br J Dermatol 134:238–246
Peters MJ, Foitzik K, Paus R, Ray S, Holick MF (2001) A new strategy for modulating chemotherapy-induced alopecia, using PTH/PTHrP receptor agonist and antagonist. J Invest Dermatol 117:173–178
Pitcher T, Pettifor JM, Buffenstein R (1994) The effect of dietary calcium content and oral vitamin D3 supplementation on mineral homeostasis in a subterranean mole-rat Cryptomys damarensis. Bone Miner 27:145–157
Prescott GW (1968) The algae: a review. Boston, Houghton Mifflin, Co
Reid IR, Gallagher DJA, Bosworth J (1985) Prophylaxis against vitamin D deficiency in the elderly by regular sunlight exposure. Age Ageing 15:35–40
Rostand SG (1979) Ultraviolet light may contribute to geographic and racial blood pressure differences. Hypertension 30:150–156
Schilli MB, Ray S, Paus R, Obi-Tabot E, Holick MF (1997) Control of hair growth with parathyroid hormone (7–34). J Invest Dermatol 108:928–932
Schwartz GG, Whitlatch LW, Chen TC, Lokeshwar BL, Holick MF (1998) Human prostate cells synthesize 1,25-dihydroxyvitamin D3 from 25-hydroxyvitamin D3. Cancer Epidemiol Biomarkers Prev 7:391–395
Sedrani SH (1984) Low 25-hydroxyvitamin D and normal serum calcium concentrations in Saudi Arabia: Riyadh region. Ann Nutr Metab 28:181–185
Smith EL, Walworth ND, Holick MF (1986) Effect of 1,25-dihydroxyvitamin D3 on the morphologic and biochemical differentiation of cultured human epidermal keratinocytes grown in serum-free conditions. J Invest Dermatol 86:709–714
Sniadecki J (1939) Jerdrezej Sniadecki (1768–1838) on the cure of rickets. (1840) Cited by W. Mozolowski. Nature 143:121–121
Specker BL, Valanis B, Hertzberg V, Edwards N, Tsang R (1985) Sunshine exposure and serum 25-hydroxyvitamin D concentrations in exclusively breast-fed infants. J Pediatr 107:372–376
Steenbock H (1924) The induction of growth-prompting and calcifying properties in a ration exposed to light. Science 60:224–225
Steenbock H, Black A (1924) The induction of growth-promoting and calcifying properties in a ration by exposure to ultraviolet light. J Biol Chem 61:408–422
Stumpf WE, Sar M, Reid FA et al (1979) Target cells for 1,25-dihydroxyvitamin D3 in intestinal tract, stomach, kidney, skin, pituitary, and parathyroid. Science 206:1188–1190
Suva LJ, Winslow GA, Wettenhall REH, Hammonds RG, Martin TJ (1987) A parathyroid hormone-related peptide implicated in malignant hypercalcemia: cloning and expression. Science 237:893–896
Takeyama KI, Kitanaka S, Sato T, Kobori M, Yanagisawa J, Kato S (1997) 25-Hydroxyvitamin D3 1a-hydroxylase and vitamin D synthesis. Science 277:1827–1830
Tanaka H, Abe E, Miyaura C, Kuribayashi T, Konno K, Nishi Y et al (1982) 1,25-Dihydroxycholeciferol and human myeloid leukemia cell line (HL-60): the presence of cytosol receptor and induction of differentiation. Biochem J 204:713–719
Tangpricha V, Flanagan JN, Whitlatch LW, Tseng CC, Chen TC, Holt PR, Lipkin MS, Holick MF (2001) 25-Hydroxyvitamin D-1a-hydroxylase in normal and malignant colon tissue. Lancet 357:1673–1674
Tian XQ, Chen TC, Matsuoka LY, Wortsman J, Holick MF (1993) Kinetic and thermodynamic studies of the conversion of previtamin D3 to vitamin D3 in human skin. J Biol Chem 268:14888–14892
Webb AR, Kline L, Holick MF (1988) Influence of season and latitude on the cutaneous synthesis of vitamin D3: exposure to winter sunlight in Boston and Edmonton will not promote vitamin D3 synthesis in human skin. J Clin Endocrinol Metab 67:373–378
Whitlatch LW, Young MV, Schwartz GG, Flanagan JN, Burnstein KL, Lokeshwar BL, Rich ES, Holick MF, Chen TC (2002) 25-Hydroxyvitamin D-1-hydroxylase activity is diminished in human prostate cancer cells and is enhanced by gene transfer. J Steroid Biochem Mol Biol 81:135–140
Wortsman J, Matsuoka LY, Chen TC, Lu Z, Holick MF (2000) Decreased bioavailability of vitamin D in obesity. Am J Clin Nutr 72:690–693
Wysolmerksi JJ, Broadus AE, Zhou J, Fuchs E, Milstone M, Philbrick WM (1994) Overexpression of parathyroid hormone-related protein in the skin of transgenic mice interferes with hair follicle development. Proc Natl Acad Sci 91:1133–1137
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2003 Springer-Verlag Berlin Heidelberg
About this paper
Cite this paper
Holick, M.F. (2003). Evolution and Function of Vitamin D. In: Reichrath, J., Tilgen, W., Friedrich, M. (eds) Vitamin D Analogs in Cancer Prevention and Therapy. Recent Results in Cancer Research, vol 164. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-55580-0_1
Download citation
DOI: https://doi.org/10.1007/978-3-642-55580-0_1
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-62435-3
Online ISBN: 978-3-642-55580-0
eBook Packages: Springer Book Archive